CLINICAL QUESTION
Does exercise-based cardiac rehabilitation improve mortality rates, hospital admission rates, and health-related quality of life in adults who have heart failure (HF) with reduced or preserved ejection fraction?
EVIDENCE-BASED ANSWER
Exercise-based cardiac rehabilitation likely reduces the risk of all-cause hospital admission in adults who have HF with reduced or preserved ejection fraction.1 (Strength of Recommendation [SOR]: A, consistent, good-quality patient-oriented evidence.) Exercise-based cardiac rehabilitation likely improves short-term health-related quality of life in adults with HF with reduced or preserved ejection fraction. (SOR: A, consistent, good-quality patient-oriented evidence.) Exercise-based cardiac rehabilitation does not decrease short-term (up to 12 months) all-cause mortality compared with usual care in adults who have HF with reduced or preserved ejection fraction. (SOR: B, inconsistent or limited-quality patient-oriented evidence.)
PRACTICE POINTERS
HF is a common condition affecting more than 60 million people worldwide.1,2 HF is a clinical syndrome with signs and/or symptoms caused by structural and/or functional cardiac abnormalities.3 In this Cochrane review, patients who had HF with preserved ejection fraction (HFpEF) were defined as having an ejection fraction of 45% or greater, and patients with HF with reduced ejection fraction (HFrEF) were defined as having an ejection fraction of less than 45%.1 Patients with HF often experience a significant reduction in exercise capacity, which can negatively affect quality of life. Exercise-based cardiac rehabilitation is an underused treatment for cardiovascular disease to improve HF symptoms and related outcomes.4 Exercise-based cardiac rehabilitation always includes formal exercise training but may also include education on lifestyle and risk factor modification, counseling, and psychosocial support.1,4 It typically is conducted in person but also may be implemented through home-based models or technology-based models, which may increase access to this intervention.4
The authors of this Cochrane review sought to determine the effectiveness of exercise-based cardiac rehabilitation in adults (older than 18 years) with HF on all-cause mortality, mortality due to HF, all-cause hospital admission, HF-related hospital admission, and health-related quality of life.1 This updated a 2018 review and included 60 randomized controlled trials (n = 8,728) with a median follow-up time of 6 months. Most patients had HFrEF, but an increasing proportion of patients in the newer trials had HFpEF. Exercise-based cardiac rehabilitation was defined as exercise-based interventions alone or as a component of a comprehensive cardiac rehabilitation program. The control group populations did not receive exercise therapy but may have received education or psychological therapy in addition to usual medical care. Short-term follow-up was defined as less than 12 months duration and long-term follow-up was defined as 12 months or more.
Moderate-certainty evidence showed that exercise-based cardiac rehabilitation reduced short-term all-cause hospital admissions compared with usual care (risk ratio = 0.69; 95% CI, 0.56-0.86; P = .0010; number needed to treat = 13).1 In studies that used the Minnesota Living With Heart Failure questionnaire to assess health-related quality of life, short-term follow-up showed exercise-based cardiac rehabilitation likely led to a clinically important improvement in health-related quality of life (mean difference = −7.39; 95% CI, −10.30 to −4.47) where 5 or more points is considered clinically meaningful. Rehabilitation did not result in a statistically significant difference in short-term all-cause mortality.
Read the full article
Get immediate access, anytime, anywhere.
Choose a single article, issue, or full-access subscription.
Earn up to 14 CME credits per issue.
